Mirum Pharmaceuticals
MIRM
72 hedge funds and large institutions have $418M invested in Mirum Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.
420% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
92% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 12
41% more funds holding
Funds holding: 51 → 72 (+21)
17% more capital invested
Capital invested by funds: $357M → $418M (+$60.8M)
7.42% more ownership
Funds ownership: 73.79% → 81.21% (+7.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$9.73M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.54M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.32M |
| 4 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
+$3.18M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.07M |
| 2 |
Two Sigma Investments
New York
|
-$743K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$677K |
| 4 |
Goldman Sachs
New York
|
-$442K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$225K |
MIRM Hedge Fund Activity: Q4 2020 in Review
72 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2020, worth a combined $418M — up 17% from $357M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MIRM positions and 5 closed out — a net gain of 21 holders — while 23 added to existing stakes and 12 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $9.73M. The largest seller was Fidelity Investments, cutting an estimated $1.07M.
- 72 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2020, up from 51 in Q3 2020.
- Funds reported $418M of Mirum Pharmaceuticals stock for Q4 2020, up 17% quarter-over-quarter.
- 26 funds opened new Mirum Pharmaceuticals positions in Q4 2020 and 5 closed out, a net change of +21 holders.
- The largest Mirum Pharmaceuticals buyer in Q4 2020 was Sio Capital Management, an estimated $9.73M added.
- The largest Mirum Pharmaceuticals seller in Q4 2020 was Fidelity Investments, an estimated $1.07M sold.
Based on aggregated 13F filings for Q4 2020.